Crandall Susan

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 91% 68% 82%
Transactions
7 71% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 2%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Crandall Susan's trades of Hikma Pharmaceuticals PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
318.90
Quantity 25,582
Value £4,066,643
Transaction date
Purchase
Price
356.23
Quantity 81,520
Value £3,968,179
Transaction date
Sale
Price
113.99
Quantity 25,161
Value £612,213
Transaction date
Purchase
Price
19.03
Quantity 621
Value £11,818
Transaction date
Sale
Price
22.03
Quantity 25,012
Value £551,014
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-22 2026-09-21
B Purchase
25,582
318.90
£4,066,643 		25,582 318.90 £4,066,643
2026-05-06 2026-05-05
B Purchase
81,520
356.23
£3,968,179 		81,520 356.23 £3,968,179
2024-12-23 2024-12-20
S Sale
25,161
113.99
£612,213 		25,161 113.99 £612,213
2024-09-24 2024-09-23
B Purchase
621
19.03
£11,818 		621 19.03 £11,818
2024-05-09 2024-05-07
B Purchase
180
19.79
£3,562 		180 19.79 £3,562
2024-05-09 2024-05-03
B Purchase
726
19.34
£14,041 		726 19.34 £14,041
2023-08-11 2023-08-10
S Sale
25,012
22.03
£551,014 		25,012 22.03 £551,014